From the Department of Pediatrics, Korea University Anam Hospital, Seoul, Republic of Korea.
Pediatr Infect Dis J. 2022 Nov 1;41(11):e456-e460. doi: 10.1097/INF.0000000000003674. Epub 2022 Aug 25.
Multisystem inflammatory syndrome in children (MIS-C) is rare but can be a potentially serious complication following SARS-CoV-2 infection in children. 1 Introduction of coronavirus disease 2019 (COVID-19) vaccines are effective in lowering the burden due to SARS-CoV-2. However, there have been reports of MIS occurrence following COVID-19 vaccination in adults. 2 The potential public health implication of MIS-C following COVID-19 vaccination is not clear in children. Our objective is to describe the spectrum of clinical disease, therapy, and outcomes of MIS-C following COVID-19 vaccination in children.
儿童多系统炎症综合征(MIS-C)较为罕见,但可能是儿童感染严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)后的一种潜在严重并发症。1 冠状病毒病 2019(COVID-19)疫苗的推出,有效降低了 SARS-CoV-2 带来的负担。然而,有报道称 COVID-19 疫苗接种后成年人会出现 MIS-C。2 COVID-19 疫苗接种后儿童出现 MIS-C 的潜在公共卫生影响尚不清楚。我们的目的是描述 COVID-19 疫苗接种后儿童 MIS-C 的临床疾病谱、治疗方法和结局。